Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) EBT Growth (3y) (2022 - 2025)

Analysis

Evotec SE (EVO) EBT Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -7.07%
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 26.04%
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn -25.51%
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -9.70%
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -26.68%
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 30.89%
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 42.03%
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 20.94%
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 44.54%
Sep 30, 2025 -46.57%
Jun 30, 2025 -6.58%
Mar 31, 2025 25.89%
Dec 31, 2024 -76.20%
Sep 30, 2024 -32.21%
Jun 30, 2024 -52.68%
Mar 31, 2024 -34.68%
Dec 31, 2023 -74.77%
Dec 31, 2022 -89.82%